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arm and cold hepatic ischemia followed by reperfu-
ion leads to necrotic cell death (oncosis), which often
ccurs within minutes of reperfusion. Recent studies
lso suggest a large component of apoptosis after is-
hemia/reperfusion. Here, we review the mechanisms
nderlying adenosine triphosphate depletion–depen-
ent oncotic necrosis and caspase-dependent apopto-
is, with emphasis on shared features and pathways.
lthough apoptosis causes internucleosomal DNA deg-
adation that can be detected by terminal deoxynucleo-
idyl transferase–mediated deoxyuridine triphosphate
ick-end labeling and related assays, DNA degradation
lso occurs after oncotic necrosis and leads to pervasive
erminal deoxynucleotidyl transferase–mediated de-
xyuridine triphosphate nick-end labeling staining far in
xcess of that for apoptosis. Similarly, although apopto-
is can occur in a physiological setting without inflam-
ation, in pathophysiological settings apoptosis fre-
uently induces inflammation because of the onset of
econdary necrosis and stimulation of cytokine and che-
okine formation. In liver, the mitochondrial permeabil-
ty transition represents a shared pathway that leads to
oth oncotic necrosis and apoptosis. When the mito-
hondrial permeability transition causes severe adeno-
ine triphosphate depletion, plasma membrane failure
nd necrosis ensue. If adenosine triphosphate is pre-
erved, at least in part, cytochrome c release after the
itochondrial permeability transition activates caspase-
ependent apoptosis. Mitochondrial permeability transi-
ion–dependent cell death illustrates the concept of
ecrapoptosis, whereby common pathways lead to both
ecrosis and apoptosis. In conclusion, oncotic necrosis
nd apoptosis can share features and mechanisms,
hich sometimes makes discrimination between the 2
orms of cell death difficult. However, elucidation of
ritical cell death pathways under clinically relevant con-
itions will show potentially important therapeutic inter-
ention strategies in hepatic ischemia/reperfusion in-
ury.
epatic ischemia/reperfusion injury occurs in diverse
circumstances, including liver surgery (e.g., a Prin-
le maneuver during tumor resection or liver trauma),iver preservation for transplantation, veno-occlusive dis-
ase, hemorrhagic shock–resuscitation, and heart failure.
ifferent injury mechanisms contribute to the overall
athophysiology of hepatic ischemia/reperfusion in-
ury.1–6 Although ischemic stress itself primes cells for
amage and will eventually cause cell death, cell injury
ften does not manifest itself until after the ischemic
iver is reperfused.7
Production of reactive oxygen species, including su-
eroxide, hydrogen peroxide, and hydroxyl radicals, has
ong been implicated in reperfusion injury, but oxygen-
ndependent factors are important as well, such as tissue
H changes during ischemia/reperfusion.8 Inflammatory
esponses2,6 and microcirculatory problems4 further ag-
ravate injury after reperfusion. Ischemia/reperfusion ac-
ivates Kupffer cells, the resident macrophages of the
iver, and functional inactivation of Kupffer cells atten-
ates injury during early and late reperfusion.9–13
upffer cells activated after reperfusion generate reactive
xygen species, proinflammatory cytokines, chemokines,
nd other mediators that contribute to postischemic
issue injury and to the systemic inflammatory response
yndrome and multiorgan failure that may follow a se-
ere ischemic insult to the liver.14 Together with acti-
ated complement factors,15 these inflammatory media-
ors activate and recruit neutrophils into the
ostischemic liver,16,17 which generates even more reac-
ive oxygen18,19 and releases additional proteases and
ther degradative enzymes.20 In addition to the inflam-
atory response, vasoconstriction of sinusoids induced
y endothelin-121 promotes heterogeneous closure of
any microvessels, which prolongs ischemia in certain
reas of the liver even after reperfusion.22
Abbreviations used in this paper: IB, inhibitor of nuclear factor B;
PT, mitochondrial permeability transition; NFB, nuclear factor-B;
NF, tumor necrosis factor; TUNEL, terminal deoxynucleotidyl trans-
erase–mediated deoxyuridine triphosphate nick-end labeling.






























Most of the described mechanisms of reperfusion in-
jury generally assume cell damage that involves oncotic
necrosis. However, several recent reports propose that
apoptosis occurs in postischemic heart, liver, and other
tissues.23–25 Postischemic apoptosis would seem to con-
tradict earlier findings of necrotic cell death. Thus, con-
fusion and uncertainty exist concerning the actual mode
of cell killing after ischemia/reperfusion. Accordingly,
the goal of this overview is to discuss the distinctions
between apoptosis and necrosis and to evaluate critically
the methods and approaches used to quantify apoptotic
and necrotic cell death to reach conclusions regarding the
pathophysiological role of each mode of cell death in
hepatic ischemia/reperfusion injury.
Oncotic Necrosis (Oncosis) in
Ischemia/Reperfusion Injury
The primary stress in ischemia to liver and most
other solid tissues is loss of mitochondrial adenosine
triphosphate (ATP) production. The resulting ATP de-
pletion leads to cellular swelling, rounding and swelling
of mitochondria, dilatation of the endoplasmic reticu-
lum, and formation of plasma membrane protrusions
called blebs.26,27 Blebs are a consequence of ATP deple-
tion and likely represent a response to disrupted cellular
volume control and cytoskeletal disturbances. After
briefer periods of ischemia/anoxia, bleb formation rapidly
reverses after reoxygenation, but necrotic cell death oc-
curs after longer periods. Just before cell death, hepato-
cytes and hepatic sinusoidal cells develop a metastable
state, which is characterized by mitochondrial permeabil-
ization, lysosomal disruption, bleb coalescence and
growth, cell swelling, and leakage of anionic solutes.28–30
Opening of glycine-sensitive anion channels that conduct
chloride and various organic anions initiates the meta-
stable state and a phase of rapid colloid osmotic swell-
ing.30 Cell death then occurs by failure of the plasma
membrane permeability barrier, often caused by bleb
rupture.28,29 Plasma membrane permeabilization causes
release of cellular enzymes and other contents, labeling
with vital dyes such as trypan blue, and development of
histological changes known as necrosis. The release of
cellular contents also initiates an inflammatory response
during reperfusion. Over time, macrophages gradually
resorb the remnants of the necrotic tissue, which is
replaced by scar tissue. Taken together, the observations
of postischemic cell swelling, vacuolation, karyolysis,
and cell content release, affecting cells in large areas of
the tissue in combination with a substantial inflamma-
tory response, are characteristic features of a necrotic cell




The original description of apoptotic cell death
was based on morphology.32 The classic morphological
features of apoptosis include cellular shrinkage, nuclear
condensation, chromatin margination, and fragmenta-
tion of both the nucleus and cytoplasm into apoptotic
bodies, which are phagocytosed and degraded by phago-
cytes, neighboring cells, or both (Figure 1). The original
definition of apoptosis describes the cytoplasmic or-
ganelles of apoptotic cells as remaining normal in ap-
pearance, in marked contrast to necrosis, although many
more recent studies show mitochondrial swelling,
changes to the endoplasmic reticulum, increased autoph-
agy, and other cytoplasmic changes during apoptosis.33
In classic apoptotic cell death, intracellular contents are
not released, and a consequent inflammatory response
fails to develop. Functionally, apoptosis eliminates excess
and unneeded cells during development and damaged
and worn-out cells during normal tissue turnover. Char-
acteristically, apoptosis affects individual isolated cells in
a tissue, rather than groups of contiguous cells. Under
certain conditions, the apoptotic cell death program may
not go to completion. Instead, secondary necrosis super-




We first briefly review some basic background
information on apoptotic signaling pathways in hepato-
cytes to place into context the discussion of whether
postischemic cell death is caused by apoptosis. During
the last decade, dramatic progress has been made in the
elucidation of the intracellular signaling mechanisms of
apoptosis.35–39 A variety of mediators, including tumor
necrosis factor (TNF)-, Fas ligand, and tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL), acti-
vate a so-called extrinsic pathway to apoptosis. As illus-
trated for TNF- in Figure 2, these proapoptotic medi-
ators first bind to their respective receptors, which cause
receptor oligomerization and the association of various
adapter proteins, including Fas-associated death domain,
TNF- receptor–associated death domain, and TNF-
receptor–associated factor. Fas-associated death domain
and TNF- receptor–associated death domain promote
binding of procaspase 8 and its proteolytic activation to
catalytic caspase 8. If sufficient amounts of caspase 8 are
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generated at the receptor, caspase 8 can directly activate
procaspase 3 (type 1 pathway).40 However, in hepato-
cytes, the receptor signal needs to be amplified through
mitochondria (type 2 pathway).40,41 Caspase 8 cleaves
Bid, a BH3 domain-only Bcl-2 family member, to an
active fragment, tBid, which translocates to mitochon-
dria. tBid translocation leads to release of soluble pro-
teins from mitochondria that activate caspases and initi-
ate apoptotic nuclear changes.41 These protein factors
include cytochrome c, apoptosis-inducing factor, and
Smac/Diablo, which reside in the intermembrane space
between the mitochondrial inner and outer mem-
branes.42–45
The mechanisms that induce the release of mitochon-
drial intermembrane proteins remain controversial. In
hepatocytes, TNF-– and Fas-dependent signaling in-
duces the onset of the mitochondrial permeability tran-
sition (MPT). The MPT occurs from the opening of a
pore, the permeability transition pore, which is highly
conductive to solutes of molecular weight up to approx-
imately 1500 daltons.46 As a consequence of permeabil-
ity transition pore opening, mitochondria depolarize,
uncouple, and undergo large amplitude swelling. This
Figure 1. Liver histology of galactosamine-induced apoptosis. Char-
acteristic morphology is shown of rat hepatocytes undergoing apopto-
tic cell death 6 hours after treatment with galactosamine (500 mg/
kg). Features of apoptosis include cell shrinkage (1), chromatin
margination (2), chromatin condensation and fragmentation (3), and
formation of apoptotic bodies (4).
Figure 3. Trypan blue staining and TUNEL labeling after cold liver
storage and orthotopic rat liver transplantation. A rat liver was stored
in cold University of Wisconsin solution for 44 hours and transplanted
into a recipient rat. After 15 minutes of implantation, the liver graft
was infused with trypan blue and fixed. The upper panel shows trypan
blue uptake into the nuclei of nonviable cells, indicating oncotic
necrosis, whereas the lower panel shows TUNEL-positive nuclei la-
beled with green fluorescence, indicating DNA strand breaks. Note
that all TUNEL-positive cells stain with trypan blue (arrows), whereas
some trypan blue–labeled cells stain weakly or not at all with TUNEL
(double arrows). (X.-X. Peng, et al., unpublished data, January 2003).
Figure 2. Scheme of apoptotic signaling in hepatocytes. AIF, apopto-
sis-inducing factor; APAF-1, apoptosis-activating factor-1; IKK, IB
kinase; TRADD, tumor necrosis factor- receptor–associated death
domain; TRAF, tumor necrosis factor- receptor–associated factor.
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swelling causes a rupture of the outer membrane and a
release of proteins from the intermembrane space. Other
mechanisms for cytochrome c release also seem to exist.
In some models, tBid interaction with either Bax or Bak,
2 other proapoptotic members of the Bcl-2 family, forms
channels in the mitochondrial outer membrane that re-
lease cytochrome c and a number of other, larger proteins
from the intermembrane space. The nature and compo-
sition of these channels, however, remain poorly under-
stood.43,47,48 Bcl-2 and other antiapoptotic Bcl-2 family
members block cytochrome c release. The mechanism for
the antiapoptotic action of Bcl-2 may involve blockade of
the MPT and/or antagonism of Bax/Bak-dependent pore
formation in the mitochondrial outer membrane.
After its release from mitochondria, cytochrome c
forms a complex with apoptosis-activating factor-1, ATP
(or deoxyadenosine triphosphate), and procaspase 9 (Fig-
ure 2). This complex, called an apoptosome, proteolytically
activates caspase 9, which in turn activates procaspase 3
to caspase 3.49 Through action on a variety of substrates,
caspase 3 activity initiates the final execution stages of
apoptosis, including cell shrinkage, surface blebbing,
internucleosomal DNA hydrolysis, phosphatidyl serine
externalization on the plasma membrane, chromatin
margination, and nuclear lobulation.
In general, the type 2 apoptotic signaling pathway
through the mitochondria, as it occurs in hepatocytes, is
faster than the type 1 pathway and can be better regu-
lated. However, if the type 2 pathway is blocked by
inhibition of the MPT with cyclosporin A, caspase 3
activation and apoptosis will still occur, but at a slower
rate, via a type 1 pathway, but without mitochondrial
depolarization, the MPT, or cytochrome c release (Figure
2).50 Adding to this redundancy is the so-called intrinsic
pathway to apoptosis51 (Figure 2). Such pathways may or
may not involve p53-dependent gene expression but may
activate apoptosis by still incompletely understood
mechanisms through translocation of Bax and other pro-
apoptotic Bcl-2 family members to the mitochondria to
cause cytochrome c release and the activation of caspases
9 and 3.
Death receptors also initiate survival signals. For ex-
ample, ligation and oligomerization of TNF- receptors
and Fas promote receptor association of another adapter
protein, TNF- receptor–associated factor. TNF- re-
ceptor–associated factor in turn initiates inhibitor of
nuclear factor-B (IB) kinase activation, IB phosphor-
ylation, and subsequent degradation of IB in proteo-
somes. The disappearance of IB de-represses nuclear
factor-B (NFB), which translocates to the nucleus to
induce expression of several antiapoptotic genes that
prevent apoptosis from occurring, including inhibitor-
of-apoptosis proteins (Figure 2).52,53 Survival signaling
through NFB is so strong that to induce apoptosis in
cultured hepatocytes, NFB-dependent gene expression
must be blocked by using protein or messenger RNA
synthesis inhibitors or by expressing an IB superrepres-
sor that has been mutated to lack a phosphorylation site
for IB kinase.54
Assessment of Apoptotic Cell
Death
As a result of an increasing understanding of the
mechanisms and pathways to apoptotic cell death, more
and more biochemical and immunologic assays are being
developed and used to characterize apoptosis (Table 1).
Today, apoptosis can be monitored in vitro and in vivo
Table 1. Assays for Apoptosis
Nuclear morphology (chromatin condensation and nuclear lobulation/fragmentation) in histological sections and after fluorescent staining
with DAPI, propidium iodide, and so on
Internucleosomal DNA cleavage (DNA ladder after starch gel electrophoresis; ELISA for DNA fragments)
TUNEL and related assays (in situ detection of double-stranded DNA breaks)
Annexin V (phosphatidyl serine externalization)
Caspase assays (especially caspases 3, 2, 8, and 9)
Enzyme assays using fluorogenic substrates
Immunocytochemistry with specific antibodies against activated caspases
Western blotting to show a decrease of the proenzyme and the appearance of active fragments
Cleavage of caspase substrates (e.g., PARP cleavage)
Nuclear staining with supravital dyes for secondary necrosis (trypan blue; propidium iodide)
Mitochondrial depolarization assessed with potential-indicating fluorophores (rhodamine 123, tetramethylrhodamine methylester, JC-1, and
so on)
Cytochrome c release into cytosol (Western blot; immunocytochemistry)
Translocation of proapoptotic proteins (Bax, Bid, and so on) to mitochondria; proteolytic cleavage of Bid (Western blot;
immunocytochemistry)
DAPI, 4,6-diamidino-2-phenylindole; ELISA, enzyme-linked immunosorbent assay; JC-1, 5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazolyl
carboxycyanine iodide. PARP, poly (adenosine diphosphate–ribose) polymerase.
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by such diverse techniques as enzyme assays for activated
caspases, Western blot analyses for caspase processing,
annexin V labeling for phosphatidyl serine externaliza-
tion, cleavage of poly (adenosine diphosphate–ribose)
polymerase and other targets of caspase 3 proteolytic
action, trypan blue and propidium iodide staining, and
mitochondrial depolarization and cytochrome c release,
in addition to classic morphological criteria. In particu-
lar, a distinctive form of random DNA cleavage between
nucleosomes occurs in apoptosis, which produces DNA
fragments in multiples of approximately 190 base pairs
(the length of DNA from 1 nucleosome to the next). This
pattern of DNA cleavage produces a characteristic lad-
dering pattern after gel electrophoresis. Other methods
to assess DNA cleavage are by enzyme-linked immu-
nosorbent assay kits that detect DNA fragments and by
the terminal deoxynucleotidyl transferase–mediated de-
oxyuridine triphosphate nick-end labeling (TUNEL) as-
say (Table 1).
It is important to note that apoptosis represents a
constellation of events, and no single change is necessar-
ily a required event in apoptosis or is unique to apopto-
sis. For example, mitochondrial depolarization, swelling,
and cytochrome c release also typically occur in oncotic
necrosis, and the trypan blue and propidium iodide
labeling of so-called late apoptosis actually represents a
phenomenon of secondary necrosis associated with loss of
plasma membrane integrity. Necrotic cell death also
leads to annexin V labeling,55 because after lysis of the
plasma membrane, annexin V gains entrance to the in-
terior of cells and the internal surface of the plasma
membrane, where phosphatidylserine normally resides.
Caspase 3 activation is perhaps most uniquely associated
with apoptosis, but not all forms of apoptosis require
caspase 3 activation.
Necrosis also causes DNA cleavage, although such
cleavage is not characteristically internucleosomal. On
gel electrophoresis, such cleavage leads to a smear of
many different molecular weight fragments rather than a
ladder pattern of multiples of 190 base pairs. However,
DNA fragmentation with a ladder pattern was also re-
ported during necrosis.56,57 Calcium-dependent activa-
tion of endonucleases may be responsible for this effect.58
Techniques such as the TUNEL assay may not distin-
guish the internucleosomal DNA cleavage of apoptosis
from the much less ordered DNA cleavage of necrosis. In
liver and other tissues, TUNEL labeling occurs during
ischemic necrosis and after toxicant-induced necrotic cell
killing.59–61 Indeed, after reperfusion of livers stored for
transplantation, the same cells showing TUNEL label-
ing, a presumptive indicator of apoptosis, also labeled
with trypan blue, an indicator of oncotic necrosis,
whereas not all trypan blue–stained cells labeled with
TUNEL (Figure 3). These observations are consistent
with postnecrotic DNA hydrolysis as the basis for
TUNEL conversion in necrotic tissue, as previously pro-
posed.59–61
Overall, the most reliable method to identify apopto-
tic cell death is morphology. Vital dyes and simple
histology can readily visualize nuclear morphology (chro-
matin condensation and fragmentation). Once apoptosis
as the mode of cell death is established by the character-
istic morphological changes, any number of other param-
eters listed in Table 1 can be used to further support the
hypothesis and delineate specific signaling pathways.
Apoptotic Cell Death During Hepatic
Ischemia/Reperfusion
The first report of apoptotic cell death during
hepatic ischemia/reperfusion appeared in 1996.24 Similar
reports of postischemic apoptosis have appeared for heart,
brain, and other organs.23,62,63 In liver after 60 minutes
of warm ischemia, the number of apoptotic hepatocytes
evaluated by nuclear morphology increases during the
first 24 hours of reperfusion.24 Using the TUNEL assay,
another study identified apoptotic hepatocytes in human
allografts after transplantation.64 Subsequent studies re-
ported that sinusoidal endothelial cells undergo apopto-
sis during cold ischemia/reperfusion25 and that both
sinusoidal endothelial cells and hepatocytes undergo ap-
optosis after warm ischemia/reperfusion.65 These obser-
vations were based largely on fluorescence TUNEL assays
and DNA laddering in gels. In addition, electron mi-
croscopy showed that single cells meet the morphological
definition of apoptosis.25,65 Further, pancaspase inhibi-
tors attenuated reperfusion injury after warm and cold
ischemia.66,67 By the criteria of TUNEL labeling, 60% to
80% of sinusoidal endothelial cells and hepatocytes un-
dergo apoptosis within 6 hours of reperfusion.65,67 Fur-
ther studies suggested that Kupffer cells and platelets are
responsible for inducing apoptosis in these liver cells
through the release of TNF-.68,69
Despite the growing literature on apoptotic cell death
after hepatic ischemia/reperfusion, concerns exist regard-
ing the interpretation of these results and the relevance of
apoptosis in the pathophysiology of reperfusion injury.
The onset of necrotic cell death as judged by enzyme
release and staining with trypan blue and propidium
iodide occurs within minutes of reperfusion (see Figure
3).70–72 After warm ischemia, reperfusion-induced on-
cotic necrosis occurs predominantly in hepatocytes and is
accompanied by enzyme release.71,73 After cold ischemia
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during liver preservation for transplantation, necrotic
death occurs nearly exclusively in sinusoidal endothelial
cells and is accompanied by relatively little enzyme
release because of the much smaller cytoplasmic mass of
the endothelial cells.7,70 The extent of this reperfusion-
induced necrotic cell killing correlates well with graft
failure after transplantation. When strict morphological
criteria in combination with the TUNEL assay are used,
apoptosis of endothelial cells and hepatocytes after 45 to
120 minutes of warm ischemia can be confirmed, but
quantitatively apoptosis never exceeds 2% of the liver
cells at risk.74 Furthermore, necrotic cell death, identified
by cell swelling, karyorrhexis, karyolysis, and vacuoliza-
tion, accounts for more than 90% of all cell death,
although many of the necrotic cells are TUNEL posi-
tive.74 The relatively minor component of apoptotic cell
death after reperfusion is consistent with several other
reports.24,75–77 The limited amount of apoptotic cell
death also correlates with limited or absent activation of
caspases.74 In contrast, during Fas- and TNF receptor–
induced apoptosis in vivo, which affects approximately
15%–30% of hepatocytes, caspase 3 activity levels in-
crease 10- to 20-fold or more, and extensive processing of
procaspase 3 occurs78,79—features that are nearly absent
after ischemia/reperfusion.74
Characteristically, apoptosis occurs in individual iso-
lated cells. Even if large numbers of hepatocytes are
induced in vivo to undergo apoptosis after activation of
Fas or TNF receptors, individual cells rather than groups
of contiguous cells show apoptotic features (Figure 4B).
In contrast, oncotic necrosis typically occurs in confluent
areas of adjacent cells (Figure 4C and D).61,80,81 After
Figure 4. Hepatic TUNEL staining in TNF-–induced apoptosis and acetaminophen-induced oncotic necrosis. Mice were untreated (A), received
700 mg/kg galactosamine and 100 g/kg endotoxin for 6 hours (B), or were treated with 300 mg/kg acetaminophen for 4 hours (C) or 6 hours
(D). The assay shows a selective nuclear staining of individual hepatocytes during apoptosis (B) compared with the nuclear/cytosolic staining
of contiguous cells in the centrilobular region of early oncotic necrosis after acetaminophen (C). Because of the more extensive karyolysis at later
stages of oncotic necrosis, nuclear staining is less prominent in most cells compared with the cytosolic staining after 6 hours of acetaminophen
treatment (D). CV, central vein.
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hepatic ischemia/reperfusion, this necrosis typically oc-
curs in the pericentral and midzonal regions of the
hepatic lobule, because these regions are furthest re-
moved from the oxygen supply.5,74 These observations
are consistent with the conclusion that the main mode of
cell death during reperfusion injury is oncotic necrosis.
Another argument for apoptosis as the principal mode
of cell killing after ischemia/reperfusion is the protective
effect of Bcl-2 overexpression.82 Bcl-2 interrupts apopto-
tic signaling at the level of the mitochondria38 and
prevents Fas-induced hepatocellular apoptosis.83 How-
ever, Bcl-2 overexpression also inhibits necrotic cell
death in hepatocytes and other cell types, possibly by
inhibiting the MPT.84,85 Oncosis can have other similar-
ities to apoptosis, such as translocation of Bax to the
mitochondria86 and release of mitochondrial cytochrome
c (without caspase 3 activation)87 during acetaminophen-
induced oncotic necrosis. Thus, identification of apopto-
sis as the principal mode of cell death requires evaluation
of several parameters, which should qualitatively and
quantitatively correlate with the extent of the assumed
apoptosis.
Despite the predominance of necrosis over apoptosis
after hepatic ischemia/reperfusion, several groups report
protection by caspase inhibitors during ischemia/reper-
fusion.66,67 However, protection may be rather modest,
even with potent pancaspase inhibitors. For example,
pancaspase inhibitors delay liver graft failure after pro-
longed cold ischemic storage by only approximately a
day, without improvement of long-term graft survival.67
This small and ultimately clinically irrelevant prolonga-
tion of survival may be due to anti-inflammatory effects,
because pancaspase inhibitors block interleukin-1– con-
verting enzyme (later renamed caspase 1), an enzyme
involved in activating interleukin-1 and some other
proinflammatory cytokines.88 Apoptosis in a pathophys-
iological setting often promotes inflammation,89 which
in turn can extend and accelerate tissue injury.17 During
Listeria infection, hepatocellular apoptosis can promote
neutrophil recruitment into the liver.90 Moreover, TNF-
induced parenchymal apoptosis triggers neutrophil
transmigration and massive aggravation of the injury in
an endotoxemia model.91,92 Although the exact signaling
mechanisms are not completely understood, apoptotic
hepatocytes generate CXC chemokines,93 which can sig-
nal neutrophil infiltration. A proinflammatory role of
apoptosis in hepatic ischemia/reperfusion injury is also
implied by findings that pancaspase inhibition decreases
neutrophil recruitment into the liver, with attenuation of
reperfusion injury.94 Thus, apoptosis, even if limited to a
relatively small number of cells, still has the potential to
affect overall injury by contributing to the amplification
of the inflammatory response.
Necrapoptosis
Part of the confusion concerning the roles of
apoptosis and necrosis in ischemia/reperfusion and other
forms of hepatic injury arises from the assumption that
apoptotic and necrotic mechanisms are distinct and sep-
arate when, in fact, these mechanisms can be shared. In
particular, the MPT plays an important role in oncotic
necrosis, as well as in apoptosis. In ischemia, anaerobic
glycolysis and ATP hydrolysis during ischemia rapidly
decrease tissue pH, which protects strongly against ne-
crotic cell killing despite profound ATP depletion.95,96
Payback occurs when physiological pH returns after
reperfusion, and the recovery of normal intracellular pH
is an independent factor for precipitating lethal cellular
reperfusion injury.70,71,97 The mechanism of pH-depen-
dent reperfusion injury involves onset of the MPT, a
phenomenon that is inhibited by pH 7. Initially after
reperfusion of hepatocytes in a cell culture model, mito-
chondria begin to repolarize, but as the intracellular pH
approaches 7, mitochondria undergo inner membrane
permeabilization, depolarization, and large-amplitude
swelling.72
After onset of the MPT, mitochondrial uncoupling
and activation of the mitochondrial uncoupler–stimu-
lated adenosine triphosphatase lead to profound ATP
depletion and ATP depletion–dependent necrotic cell
death.72 Cyclosporin A, a specific inhibitor of the MPT,
prevents MPT-induced mitochondrial depolarization, in-
ner membrane permeabilization, and ATP exhaustion
after reperfusion and blocks the necrotic cell killing that
ensues. The importance of ATP depletion is illustrated
by the ability of the ATP-generating glycolytic substrate
fructose to prevent this necrotic cell death. Only 15% to
20% of normal ATP is sufficient to prevent such necrotic
cell killing.98,99 Cytoprotection by fructose is down-
stream of the MPT, because fructose does not prevent the
mitochondrial depolarization and inner membrane per-
meabilization induced by MPT-inducing treatments.100
MPT-dependent necrotic cell death in models of isch-
emia/reperfusion to cultured hepatocytes is not blocked
by caspase inhibitors and occurs without TUNEL stain-
ing.101 The absence of TUNEL staining may reflect the
release and dilution into the medium of nucleases after
plasma membrane permeabilization.
However, when necrotic cell death is prevented by
fructose, caspase 3–dependent apoptosis occurs instead,
as documented by nuclear morphology, TUNEL label-
ing, and caspase activation.101 Cyclosporin A, a specific
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blocker of the MPT, still prevents this apoptosis, as do
caspase inhibitors. Thus, the MPT is an obligatory event
in both necrotic and apoptotic cell killing after ischemia/
reperfusion. But how can one event, the MPT, lead to
two such disparate events?
The onset of MPT leads to large-amplitude mitochon-
drial swelling, rupture of the outer membrane, and re-
lease of cytochrome c and other proteins from the inter-
membrane space between the mitochondrial inner and
outer membranes. As discussed previously, cytochrome c
interacts with apoptosis-activating factor-1 to promote
caspase 9 activation, which then activates caspase 3.
However, cytochrome c–dependent activation of caspase
9 requires ATP or the less abundant deoxyadenosine
triphosphate.42 Accordingly, the presence or absence of
ATP can act as a “switch” between apoptosis and necro-
sis.102–104 When reperfusion leads to both MPT onset
and ATP depletion, apoptotic signaling is blocked at the
level of the apoptosome, and necrosis occurs as a direct
result of the failure of ATP regeneration (Figure 5). By
contrast, if glycolytic substrate is available, profound
ATP depletion is prevented, and necrosis does not occur.
Instead, ATP-dependent apoptotic signaling occurs that
is initiated by cytochrome c release after mitochondrial
swelling. In cell-free extracts, the apparent KM of ATP
for activating apoptosomes is approximately 0.4 mmol/
L,105,106 which is only approximately 10% of the ATP
concentration of normoxic hepatocytes. Thus, the
amount of ATP needed to prevent necrosis (15%–20% of
normoxic levels) is more than enough to permit cyto-
chrome c–dependent caspase 9 and caspase 3 activation.
Similarly, in hepatocytes exposed to calcium ionophore,
the balance between ATP depletion after the MPT and
ATP generation by glycolysis determines whether ne-
crotic or apoptotic cell death occurs.100 Thus, one mito-
chondrial event, the MPT, can lead to both apoptosis and
necrosis (Figure 5). Consistent with these in vitro find-
ings, the mode of hepatic cell death can be apoptosis after
resuscitation after a shorter period of hemorrhagic shock
when cellular ATP levels fully recover but can be oncotic
necrosis after a longer period of shock when ATP levels
remain suppressed after resuscitation.102
Just as a necrotic process can be converted to an
apoptotic one, a process that starts with classic apoptotic
signaling may switch to necrosis if ATP depletion or
another change leads to breakdown of the plasma mem-
brane permeability barrier. Apoptosis resulting in such
secondary necrosis typically occurs during Fas antibody–
induced hepatocellular injury in vivo.34 In Fas receptor
ligation–dependent liver injury, mitochondrial cyto-
chrome c release, activation of the caspase cascade, DNA
fragmentation, and morphological changes characteristic
of apoptosis occur before the onset of secondary necrosis,
with hepatocellular enzyme release and inflammatory
changes.34,78,79 Thus, in an apoptotic process that ulti-
mately culminates in secondary necrosis, apoptotic
mechanisms nonetheless remain clearly identifiable by
morphological and biochemical parameters at earlier
times.
The ability of a necrotic process to be converted to an
apoptotic one and vice versa illustrates that apoptotic and
necrotic cell death are not necessarily distinct and inde-
pendent events. To the contrary, pathways leading to
necrosis and apoptosis can be shared, a phenomenon
called necrapoptosis or aponecrosis.107,108 In necrapoptosis,
events such as the MPT initiate a chain reaction that
Figure 5. Scheme of mitochondrial permeability transition (MPT)–
dependent events in necrapoptosis. Ischemia/reperfusion, death-
receptor activation, mitochondrial Ca2 loading, and reactive oxygen
species (ROS) are some of the events that promote onset of the MPT.
If MPT onset occurs in relatively few mitochondria, the organelles
become sequestered into autophagosomes for lysosomal digestion, a
process that eliminates the damaged and potentially toxic mitochon-
dria. When the MPT involves more mitochondria, mitochondrial swell-
ing leads to outer membrane rupture and cytochrome c release.
Provided that ATP is available from glycolysis and still-intact mitochon-
dria, cytochrome c activates downstream caspases and other execu-
tioner enzymes of apoptosis. When MPT onset is abrupt and involves
most mitochondria, ATP becomes profoundly depleted, which blocks
caspase activation. Instead, ATP depletion leads to the opening of a
glycine-sensitive organic anion channel to initiate a metastable state
that culminates with plasma membrane rupture and the onset of
necrotic cell death. If ATP depletion occurs during downstream apo-
ptotic signaling, then secondary necrosis may supervene. CsA, cyclo-
sporin A.
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culminates in either apoptosis or necrosis, depending on
other variables, such as ATP supply (Figure 5). By in-
ducing the MPT, ischemia/reperfusion causes both apo-
ptosis and necrosis, although in a particular circumstance
one or the other may predominate. The concept of necra-
poptosis explains why features of apoptosis and necrosis
often coexist in liver and other tissues, especially after
pathologic insults such as ischemia/reperfusion or drug-
induced liver injury. Recent work also suggests that
limited onset of the MPT induces autophagy, a process
by which effete, damaged, or superfluous mitochondria
and other organelles are eliminated from cells by lysoso-
mal degradation.109 Thus, the concept of MPT-depen-
dent necrapoptosis explains how injury can progress from
reversible changes associated with tissue repair to apo-
ptosis and then to necrosis. When the MPT occurs in
only a few mitochondria, autophagy is stimulated, and
the involved mitochondria are segregated for lysosomal
degradation without stimulation of apoptotic signaling.
With greater injury and more widespread MPT induc-
tion, apoptosis develops because of cytochrome c–depen-
dent caspase activation. With even greater injury and
MPT induction, ATP decreases to levels that no longer
support apoptotic signaling, and oncotic necrosis devel-
ops instead (Figure 5).
Conclusions
In liver, oncotic necrosis and apoptosis share fea-
tures and mechanisms. DNA degradation after necrosis
causes TUNEL labeling, which may be incorrectly inter-
preted as apoptotic cell death. During apoptosis in
pathophysiological settings, inflammatory responses and
enzyme release occur that resemble a necrotic process.
Frequently, oncotic necrosis and apoptosis coexist after
toxic, hypoxic, and inflammatory liver injury. The coex-
istence of the 2 patterns of cell death likely reflects shared
mechanistic pathways. Experimental or clinical settings
will determine whether cells die predominantly by apo-
ptosis or oncotic necrosis. Therefore, it is important to
evaluate critical cell death pathways under clinically
relevant conditions to discover new therapeutic interven-
tion strategies in hepatic ischemia/reperfusion injury.
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